Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term signaling pathways. Found 6 abstracts

Ralff MD, El-Deiry WS. TRAIL pathway targeting therapeutics. Expert Rev Precis Me. 2018 May;3(3):197-204.   PMCID: PMC6366666
Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC. Loss of the Birt-Hogg-Dube tumor suppressor results in apoptotic resistance due to aberrant TGF beta-mediated transcription. Oncogene. 2011 Jun;30(22):2534-46.   PMCID: PMC3109270
Banumathy G, Cairns P. Signaling pathways in renal cell carcinoma. Cancer Biology & Therapy. 2010 Oct;10(7):658-64.   PMCID: PMC3093809
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin - art. no. 314. Molecular Cancer. 2010 Dec;9:314.   PMCID: PMC3016286
Xiao A, Yin CY, Yang CY, Di Cristofano A, Pandolfi PP, Van Dyke T. Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. Cancer Research. 2005 Jun 15;65(12):5172-80.   PMCID: not NIH funded
Schurmann A, Mooney AF, Sanders LC, Sells MA, Wang HG, Reed JC, Bokoch GM. p21-activated kinase 1 phosphorylates the death agonist Bad and protects cells from apoptosis. Molecular and Cellular Biology. 2000 Jan;20(2):453-61.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term signaling pathways

Last updated on Thursday, April 02, 2020